CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
In a move that continues to add to the evidence that hormone replacement therapy may be dangerous, Scandinavian researchers on Tuesday called off a study on HRT for women with a history of breast cancer because early results showed an "unacceptably high" risk of recurrence. Their findings, published Tuesday in The Lancet, add to the already solid evidence that using hormone replacement to control menopausal symptoms such as hot flashes and prevent brittle bones carries significant health risks. Eighteen months ago, U.S. government scientists abruptly ended the nation's biggest study of HRT using the combined hormones estrogen and progestin, saying long-term use significantly increases women's risk of breast cancer, strokes, and heart attacks. That study involved older women who were well past menopause. Last year, a U.K. study concluded that women receiving HRT had a 22% higher risk of death from breast cancer than women who were not and that those who used estrogen and progestin together had a markedly higher risk than those who used estrogen alone. The Scandinavian researchers, led by Lars Holmberg from University Hospital in Uppsala, Sweden, had intended to follow their patients for five years. They said they called off the study on December 17 based on results from 345 women they had been following for an average of two years. Half the women were given HRT, and the other half the best nonhormonal treatment for menopausal symptoms. In the HRT group, 26 women had a recurrence or a new case of breast cancer. That compared with seven women among those who took the other treatment. At the American Cancer Society, Harmon Eyre noted that doctors occasionally offer hormone replacement to breast cancer survivors with severe menopausal symptoms because a handful of small, preliminary studies showed no risk. "This study will no doubt change that," said Eyre. "It is large enough and clear enough to show that HRT appears to increase the chance of a new or recurring breast cancer."
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Meet all 37 of the queer women in this season's WNBA
April 17 2024 11:24 AM
Here are the 15 gayest travel destinations in the world: report
March 26 2024 9:23 AM
21+ steamy photos of Scotland’s finest gay men in Elska Glasgow
February 01 2024 10:07 PM
More Than 50 of Our Favorite LGBTQ+ Moms
May 12 2024 11:44 AM
Conjoined twins Lori Schappell and trans man George Schappell dead at 62
April 27 2024 6:13 PM
Latest Stories
Kamala Harris rides wave of Democratic energy at kickoff event in Wisconsin
July 23 2024 3:36 PM
'Devastated:' A six-week abortion ban will go into effect in Iowa next week
July 23 2024 2:28 PM
Four hours, 44,000 Black women, and one Zoom call
July 23 2024 2:17 PM
Record 1.2 million people show out for Cologne’s Pride parade
July 23 2024 10:51 AM
Here's how far-right activist Leonard Leo helped fund Bud Light boycott
July 23 2024 10:27 AM
Elon Musk’s comments about his trans daughter prove why she doesn’t speak to him
July 23 2024 9:16 AM
Nancy Pelosi endorses Kamala Harris for president
July 22 2024 4:07 PM